Methotrexate for recurrent chronic rhinosinusitis with nasal polyps: A randomized, controlled, phase 2 clinical trial

ConclusionLow-dose MTX was a safe and effective maintenance therapy for patients with recurrent postoperative CRSwNPs.

Source: International Forum of Allergy and Rhinology - January 19, 2023 Category: Allergy & Immunology Authors: Asli Cakir Cetin, Yesim Tuncok, Pembe Keskinoglu, Mualla Aylin Arici, Fatos Onen, Mustafa Cenk Ecevit Tags: ORIGINAL ARTICLE Source Type: research